Case Studies / fPELA turbo

A Game Changer for Faecal Elastase Testing

Switching to the new fPELA turbo assay for improved workflow and efficiency Kaleem Fayyaz, Blood Sciences Team Leader, Spire Manchester Hospital Spire Healthcare is a leading UK independent hospital group.

Introduction of the Random Access Measuring BÜHLMANN fPELA® turbo on Roche cobas® 8000

An interview with Yvonne Schallberger, Bioanalytica, Lucerne, Switzerland Mrs. Schallberger decided to introduce the BÜHLMANN fPELA® turbo Test, that measures in random access as well as in batch mode the

Optimisation of Lab Processes by Introducing the BÜHLMANN fPELA® turbo on Beckman Coulter AU 5800

Testimonial from Angela Suter and Dr. Cyril Fuhrer, Synlab Suisse SA, Lucerne, Switzerland You are successfully performing routine faecal calprotectin measurements with the BÜHLMANN fCAL® turbo Assay on the Beckman

Successful Implementation of the BÜHLMANN fPELA® turbo on Roche cobas® c502

A report from Dr. Marc-Antoine Bagnoud*, Dianalabs in Geneva, Switzerland Dianalabs is a mid-sized private lab founded in 1988 in Geneva, Switzerland, and part of the large swiss lab network

A New Era in Pancreatic Elastase Testing

Launched in summer 2020, the new BÜHLMANN fPELA turbidimetric immunoassay for faecal pancreatic elastase, complements the popular calprotectin fCAL turbo assay, that is widely used across the UK. Using the

Faecal Pancreatic Elastase – BÜHLMANN fPELA® turbo on cobas® c501

Dr. Jörg Oliver Thumfart, Labormedizinisches Zentrum Dr. Risch The Medical Laboratory Center Dr. Risch is a privately owned group of routine medical laboratories with 14 competence centres across Switzerland and

BÜHLMANN fPELA® turbo on cobas® c501

A report from Dr. Jörg Oliver Thumfart*, Labormedizinisches Zentrum Dr. Risch “We successfully introduced the automated, turbidimetric assay for fecal calprotectin, the BÜHLMANN fCAL® turbo, on our Roche cobas® c501